Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity for a maximum of 9.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PAs may claim a maximum of 9.00 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.
The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit. Maximum of 9.00 hours.
Objectives - After Attending This Program You Should Be Able To
Discuss new innovations and research for various neurological diseases.
Recognize common acute presentations of pediatric neurology disorders in the inpatient setting.
Identify signs of physician burnout and benefactors of physician wellness to create a positive experience for both physician and patient.
Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-‐6.2, 6.5) All individuals in a position to control the content of CE are listed in the agenda. If their name is not listed below, they disclosed that they had no financial relationships with a commercial interest.
| First Name
|| Last Name
|| Commercial Interest: Relationship
||Alexion Pharmaceutical, Biogen, Bristol Myers Squibb, Biologix, Celgene, EMD Serono, GW pharma, Genentech, Horizon, Jazz Pharma, Novartis, Sanofi/Genzyme, TG therapeutics, Viela bio, Sandoz pharma:Consultant,Alexion Pharmaceutical, Biogen, Bristol Myers Squibb, Celgene, EMD Serono, Genentech, Horizon, Novartis:Speakers Bureau,Alexion Pharmaceutical, Biogen, Bristol Myers Squibb, Biologix, Celgene, EMD Serono, GW pharma, Genentech, Horizon, Jazz Pharma, Novartis, Sanofi/Genzyme, TG therapeutics, Viela bio, Sandoz pharma:Scientific/Medical Advisory Board Member,Bristol Myers Squibb, EMD Serono, Genentech, Novartis, GW pharma, Atara biotherapeutics, Celgene, Corevitas:Research Grant Site Principal Investigator
||ceribell: Research Grant
Overall Principal Investigator